Search Results - "Kleiman, Robert B"

Refine Results
  1. 1

    Potential strategy for assessing QT/QTc interval for drugs that produce rapid changes in heart rate: Electrocardiographic assessment of the effects of intravenous remimazolam on cardiac repolarization by Kleiman, Robert B., Darpo, Borje, Thorn, Michael, Stoehr, Thomas, Schippers, Frank

    Published in British journal of clinical pharmacology (01-08-2020)
    “…Aims Remimazolam is a new, ultra‐short‐acting benzodiazepine developed for intravenous (IV) use during procedural sedation and in general anaesthesia. Two…”
    Get full text
    Journal Article
  2. 2

    Ventricular Arrhythmias Associated With Over-the-Counter and Recreational Opioids by Krantz, Mori J., Rudo, Todd J., Haigney, Mark C.P., Stockbridge, Norman, Kleiman, Robert B., Klein, Michael, Kao, David P.

    “…Epidemic increases in opioid deaths prompted policies limiting access to prescription opioids in North America. Consequently, the over-the-counter opioids…”
    Get full text
    Journal Article
  3. 3

    Evaluation of the Effect of SPN-812 (Viloxazine Extended-Release) on QTc Interval in Healthy Adults by Nasser, Azmi, Faison, Shamia L, Liranso, Tesfaye, Adewole, Toyin, Busse, Gregory D, Fava, Maurizio, Kleiman, Robert B, Schwabe, Stefan

    Published in The journal of clinical psychiatry (13-10-2020)
    “…To assess the effects of a supratherapeutic dose of SPN-812, a drug currently under investigation as a treatment for attention-deficit/hyperactivity disorder,…”
    Get full text
    Journal Article
  4. 4

    False Negative ECG Device Results May Increase the Risk of Adverse Events in Clinical Oncology Trials by Dekie, Luc, Kleiman, Robert B

    “…Sites participating in clinical trials may not have the expertise and infrastructure to accurately measure cardiac intervals on 12-lead ECGs and rely heavily…”
    Get more information
    Journal Article
  5. 5
  6. 6

    Intracellular uptake of agents that block the hERG channel can confound the assessment of QT interval prolongation and arrhythmic risk by Burashnikov, Alexander, Barajas-Martinez, Hector, Cox, Robert, Demitrack, Mark A., Fossler, Michael J., Kramer, Michael, Kleiman, Robert B., Kowey, Peter, Antzelevitch, Charles

    Published in Heart rhythm (01-12-2021)
    “…Oliceridine is a biased ligand at the μ-opioid receptor recently approved for the treatment of acute pain. In a thorough QT study, corrected QT (QTc)…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9
  10. 10

    Long-term Electrocardiographic Safety Monitoring in Clinical Drug Development: A Report from the Cardiac Safety Research Consortium by Piccini, Jonathan P, Clark, Richard L, Kowey, Peter R, Mittal, Suneet, Dunmon, Preston, Stockbridge, Norman, Reiffel, James A, Turakhia, Mintu P, Ziegler, Paul D, Kleiman, Robert B, Ismat, Fraz, Sager, Philip

    Published in The American heart journal (01-05-2017)
    “…This White Paper, prepared by members of the Cardiac Safety Research Consortium (CSRC), discusses important issues regarding scientific and clinical aspects of…”
    Get full text
    Journal Article
  11. 11

    Thorough QT/QTc Evaluation of the Cardiac Safety of Enarodustat (JTZ‐951), an Oral Erythropoiesis‐Stimulating Agent, in Healthy Adults by Pai, Sudhakar M., Yamada, Hiroyuki, Kleiman, Robert B., Zhuo, Rui, Huang, Qingtao (Mike), Koretomo, Ryosuke

    Published in Clinical pharmacology in drug development (01-08-2021)
    “…This study evaluated the effect of enarodustat on cardiac repolarization in healthy subjects. Enarodustat (20 and 150 mg [supratherapeutic dose]), placebo, and…”
    Get full text
    Journal Article
  12. 12

    A thorough QT study to assess the effects of tbo-filgrastim on cardiac repolarization in healthy subjects by Adar, Liat, Avisar, Noa, Lammerich, Andreas, Kleiman, Robert B, Spiegelstein, Ofer

    Published in Drug design, development and therapy (01-01-2015)
    “…Tbo-filgrastim is a recombinant human granulocyte colony-stimulating factor approved by the US Food and Drug Administration to reduce the duration of severe…”
    Get full text
    Journal Article
  13. 13
  14. 14

    A Novel Approach to QTc Studies: Assessing Cardiac Safety of the mTOR Kinase Inhibitor CC-223 within the Dose-Escalation/Expansion Study by Kleiman, Robert B, Chopra, Rajesh, Hans, de Haan, Hege, Kristen, James, Angela J, Wang, Xiaomin, Wu, Xiaoling, O'Mara, Edward

    Published in Blood (03-12-2015)
    “…Introduction: A variety of chemically diverse drugs are known to alter cardiac repolarization and to produce sudden cardiac death. Current regulatory…”
    Get full text
    Journal Article
  15. 15

    Endocardial mapping during sinus rhythm in patients with coronary artery disease and nonsustained ventricular tachycardia by Buxton, Alfred E., Kleiman, Robert B., Kindwall, K.Elizabeth, Josephson, Mark E.

    Published in The American journal of cardiology (15-03-1993)
    “…Programmed stimulation in patients with nonsustained ventricular tachycardia (VT) and coronary artery disease (CAD) induces sustained VT in 30 to 50% of…”
    Get full text
    Journal Article
  16. 16

    Acute and chronic cycle length dependent increase in ventricular pacing threshold by Hook, B G, Perlman, R L, Callans, D J, Hanna, M S, Kleiman, R B, Flores, B T, Marchlinski, F E

    Published in Pacing and clinical electrophysiology (01-10-1992)
    “…Several factors have been shown to influence ventricular pacing threshold in humans, including pacing lead location (endocardial vs epicardial), lead…”
    Get more information
    Journal Article
  17. 17

    Implantable cardioverter-defibrillator therapy in the absence of significant symptoms : rhythm diagnosis and management aided by stored electrogram analysis by HOOK, B. G, CELLANS, D. J, KLEIMAN, R. B, FLORES, B. T, MARCHLINSKI, F. E

    Published in Circulation (New York, N.Y.) (01-06-1993)
    “…This report describes the value of stored ventricular electrogram analysis in the diagnosis and management of patients experiencing minimal or no symptoms…”
    Get full text
    Journal Article
  18. 18

    Unique sensing errors in third-generation implantable cardioverter-defibrillators by Callans, David J., Hook, Bruce G., Kleiman, Robert B., Mitra, Raman L., Flores, Belinda T., Marchlinski, Francis E.

    “…Objectives. Third-generation cardioverter-defibrillators appear to be susceptible to unique sensing errors. This study was performed to determine the incidence…”
    Get full text
    Journal Article
  19. 19

    Comparison of simultaneous versus sequential defibrillation pulsing techniques using a nonthoracotomy system by Hsia, H H, Kleiman, R B, Flores, B T, Marchlinski, F E

    Published in Pacing and clinical electrophysiology (01-07-1994)
    “…The defibrillation threshold (DFT) using simultaneous (SIML) versus sequential (SEQ) pathways for shock delivery was compared in 16 patients with an implanted…”
    Get more information
    Journal Article
  20. 20

    Electrophysiologic and mechanical properties of single feline RV and LV myocytes by Kleiman, R B, Houser, S R

    “…With the advent of techniques to isolate large numbers of single adult mammalian ventricular myocytes, it has become possible to determine whether, as a result…”
    Get more information
    Journal Article